Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,526 | 343 | 98.4% |
| Education | $106.02 | 4 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,358 | 82 | $0 (2024) |
| Alkermes, Inc. | $607.12 | 32 | $0 (2024) |
| ITI, Inc. | $493.22 | 42 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $490.42 | 21 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $483.64 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $479.14 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $324.11 | 19 | $0 (2024) |
| Lundbeck LLC | $314.88 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $305.35 | 19 | $0 (2024) |
| Corium, LLC | $304.76 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,824 | 79 | Supernus Pharmaceuticals, Inc. ($467.79) |
| 2023 | $1,843 | 103 | ABBVIE INC. ($479.80) |
| 2022 | $1,605 | 88 | ABBVIE INC. ($437.11) |
| 2021 | $1,361 | 77 | AbbVie Inc. ($307.09) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 2 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Central Nervous System | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $37.25 | General |
| Category: Neuroscience | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Neuropsychiatry | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Neuropsychiatry | ||||||
| 07/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CNS | ||||||
| 06/10/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: ANTI-ANXIETY | ||||||
| 06/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.93 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $16.38 | General |
| 05/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/01/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 04/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: Neuropsychiatry | ||||||
| 04/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: CNS | ||||||
| 04/18/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ANTI-ANXIETY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 112 | 258 | $58,148 | $16,502 |
| 2022 | 2 | 90 | 119 | $26,765 | $5,627 |
| 2021 | 4 | 183 | 654 | $145,719 | $42,766 |
| 2020 | 3 | 98 | 127 | $27,151 | $7,727 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 129 | $36,188 | $10,631 | 29.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 56 | 129 | $21,960 | $5,871 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 59 | $16,551 | $3,371 | 20.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 45 | 60 | $10,214 | $2,256 | 22.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 297 | $83,317 | $25,875 | 31.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 75 | 320 | $54,474 | $14,913 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $4,768 | $1,101 | 23.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 12 | $3,161 | $877.20 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 47 | $13,185 | $3,621 | 27.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 45 | 63 | $10,724 | $3,195 | 29.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 17 | $3,242 | $910.52 | 28.1% |
About Amanda Boroff, APRN
Amanda Boroff, APRN is a Psychiatric/Mental Health healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2020. The National Provider Identifier (NPI) number assigned to this provider is 1972139160.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Boroff, APRN has received a total of $6,632 in payments from pharmaceutical and medical device companies, with $1,824 received in 2024. These payments were reported across 347 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,526).
As a Medicare-enrolled provider, Boroff has provided services to 483 Medicare beneficiaries, totaling 1,158 services with total Medicare billing of $72,623. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Fort Myers, FL
- Active Since 03/19/2020
- Last Updated 03/19/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1972139160
Products in Payments
- VRAYLAR (Drug) $1,358
- CAPLYTA (Drug) $560.01
- ARISTADA (Drug) $530.76
- INGREZZA (Drug) $479.14
- INVEGA SUSTENNA (Drug) $471.34
- Qelbree (Drug) $467.79
- REXULTI (Drug) $396.87
- JORNAY PM (Drug) $278.98
- LATUDA (Drug) $277.29
- NEUROSTAR TMS THERAPY SYSTEM (Device) $222.76
- ABILIFY MAINTENA (Drug) $192.88
- Azstarys (Drug) $178.52
- Austedo XR (Drug) $142.90
- AZSTARYS (Drug) $126.24
- AUSTEDO (Drug) $102.36
- HETLIOZ (Drug) $89.74
- Auvelity (Drug) $84.15
- LYBALVI (Drug) $76.36
- UZEDY (Drug) $60.09
- BELSOMRA (Drug) $54.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Fort Myers
Dylan Demars, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $19,981
Mrs. Jacqueline Bannister, Arnp, ARNP
Psychiatric/Mental Health — Payments: $10,808
Ms. Jeanne Jagodzinski, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,706
Collin Mcgrath, Dnp, Aprn, Pmhnp, DNP, APRN, PMHNP
Psychiatric/Mental Health — Payments: $3,415
Jennifer Randall, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $3,338
Marie Vancamp, Dnp, Pmhnp, DNP, PMHNP
Psychiatric/Mental Health — Payments: $2,883